Antigen-specific T cell responses following single and co-administration of tick-borne encephalitis, Japanese encephalitis, and yellow fever virus vaccines: Results from an open-label, non-randomized clinical trial-cohort
PLOS Neglected Tropical Diseases · 2025
DOI: 10.1371/journal.pntd.0012693 ↗Kurz gefasst
Klinische Studie in der Zeitschrift PLOS Neglected Tropical Diseases, 2025. Verfasst von David Wullimann und 8 weiteren Autor:innen. Beteiligte Einrichtung: Department of Medicine Huddinge, Center for Infectious Medicine, Karolinska Institutet, Stockholm, Sweden. Hauptthemen laut MEDLINE: Encephalitis, Tick-Borne, Japanese Encephalitis Vaccines, T-Lymphocytes, Yellow Fever Vaccine. Die Arbeit wurde bisher 6-mal zitiert (Crossref) und nennt 44 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Swedish Research Council, Swedish Foundation for Strategic Research, Karolinska Institutet.
Abstract (Originalsprache)
Background
Flavivirus infections pose a significant global health burden, highlighting the need for safe and effective vaccination strategies. Co-administration of different vaccines, including licensed flavivirus vaccines, is commonly practiced providing protection against multiple pathogens while also saving time and reducing visits to healthcare units. However, how co-administration of different flavivirus vaccines de facto affects immunogenicity, particularly with respect to T cell responses, is only partially understood. Methods and findings Antigen-specific T cell responses were assessed in study participants enrolled in a previously conducted open-label, non-randomized clinical trial. In the trial, vaccines against tick-borne encephalitis virus (TBEV), Japanese encephalitis virus (JEV), or yellow fever virus (YFV) were administered either individually or concomitantly in different combinations in healthy study participants. Peripheral blood samples were collected before vaccination and at multiple time points afterward. To analyze antigen-specific CD4+ and CD8+ T cell responses, PBMCs were stimulated with overlapping peptide pools from TBEV, JEV, YFV, and Zika virus (ZIKV) envelope (E), capsid (C), and non-structural protein 5 (NS5) viral antigens. A flow cytometry-based activation-induced marker (AIM) assay was used to quantify antigen-specific T cell responses. The results revealed remarkably similar frequencies of CD4+ and CD8+ T cell responses, regardless of whether vaccines were administered individually or concomitantly. In addition, administering the vaccines in the same or different upper arms did not markedly affect T cell responses. Finally, limited cross-reactivity was observed between the TBEV, JEV, and YFV vaccines, and related ZIKV-specific antigens.
Conclusions
TBEV or JEV vaccines can be co-administered with the live attenuated YFV vaccine without any markedly altered antigen-specific CD4+ and CD8+ T cell responses to the respective flaviviruses. Additionally, the vaccines can be delivered in the same or different upper arms without any significant altered influence on the T cell response. From a broader perspective, these results provide valuable insights into the outcome of immune responses following simultaneous administration of different vaccines for different but related pathogens.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Substanzen
Autor:innen und Institutionen
- Department of Medicine Huddinge, Center for Infectious Medicine, Karolinska Institutet, Stockholm, Sweden.
- Department of Infectious Diseases, Karolinska University Hospital, Stockholm, Sweden.
- Department of Clinical Sciences, Danderyd University Hospital, Karolinska Institutet, Stockholm, Sweden.
ORCID-Profile: David Wullimann, Hans-Gustaf Ljunggren
Förderung
- Swedish Research Council
- Swedish Foundation for Strategic Research
- Karolinska Institutet
- Stiftelsen för Strategisk Forskning
- Region Stockholm
Zitieren
APA
Wullimann, D., Sandberg, J. T., Akber, M., Löfling, M., Gredmark-Russ, S., Michaëlsson, J., Buggert, M., Blom, K., & Ljunggren, H. G. (2025). Antigen-specific T cell responses following single and co-administration of tick-borne encephalitis, Japanese encephalitis, and yellow fever virus vaccines: Results from an open-label, non-randomized clinical trial-cohort. PLOS Neglected Tropical Diseases. https://doi.org/10.1371/journal.pntd.0012693
Vancouver
Wullimann D, Sandberg JT, Akber M, Löfling M, Gredmark-Russ S, Michaëlsson J, et al. Antigen-specific T cell responses following single and co-administration of tick-borne encephalitis, Japanese encephalitis, and yellow fever virus vaccines: Results from an open-label, non-randomized clinical trial-cohort. PLOS Neglected Tropical Diseases. 2025. doi:10.1371/journal.pntd.0012693
BibTeX
@article{Wullimann2025,
author = {Wullimann, David and Sandberg, John Tyler and Akber, Mira and Löfling, Marie and Gredmark-Russ, Sara and Michaëlsson, Jakob and Buggert, Marcus and Blom, Kim and Ljunggren, Hans-Gustaf},
title = {Antigen-specific T cell responses following single and co-administration of tick-borne encephalitis, Japanese encephalitis, and yellow fever virus vaccines: Results from an open-label, non-randomized clinical trial-cohort},
journal = {PLOS Neglected Tropical Diseases},
year = {2025},
doi = {10.1371/journal.pntd.0012693}
}
EUVIMED